Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas

Diagnostic Cytopathology

Volumn 35, Issue 11, 2007, Pages 700-704

  Zhao, Huicong ^a   Mandich, Daniza ^a   Cartun, Richard W ^a   Ligato, Saverio ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

EUS FNAs; Immunocytochemistry; KOC; Pancreatic adenocarcinoma

Indexed keywords

K HOMOLOGY DOMAIN CONTAINING PROTEIN OVEREXPRESSED IN CANCER; K HOMOLOGY DOMAIN CONTAINING PROTEIN OVEREXPRESSED IN CANCER 88; K HOMOLOGY DOMAIN CONTAINING PROTEIN OVEREXPRESSED IN CANCER 95; MONOCLONAL ANTIBODY; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CYTOPATHOLOGY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SMEAR; TISSUE FIXATION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; RNA-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 35648961927     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20739     Document Type: Article

References (10)

1. Afify AM, Al-Khafaji BN, Kim B, et al. Endoscopic ultrasound-guided fine-needle aspiration of the pancreas. Diagnostic utility and accuracy. Acta Cytol 2003;47:341-348.
2. Bentz JS, Kochman ML, Faigel DO, et al. Endoscopic ultrasound-guided real-time fine-needle aspiration: Clinicopathologic features of 60 patients. Diagn Cytopathol 1998;18:98-109.
3. David O, Green L, Reddy V, et al. Pancreatic masses: a multi-institutional study of 364 fine-needle aspiration biopsies with histopathologic correlation. Diagn Cytopathol 1998;19:423-427.
4. Mitsuhashi T, Ghafari S, Chang CY, et al. Endoscopic ultrasound-guided fine-needle aspiration of the pancreas: Cytomorphological evaluation with emphasis on adequacy assessment, diagnostic criteria and contamination from the gastrointestinal tract. Cytopathology 2006;17:34-41.
5. Fritscher-Ravens A, Brand L, Knofel WT, et al. Comparison of endoscopic ultrasonography-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. Am J Gastroenterol 2002;97:2768-2775.
6. Nielsen J, Christiansen J, Lykke-Anderson J, et al. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999;19:1262-1270.
7. Yantiss RK, Woda BA, Fanger GR, et al. KOC (K homology domain containing protein overexpressed in cancer): A novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 2005;29:188-195.
8. McCarthy DM, Maitra A, Argani P, et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: Mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol 2003;11:238-243.
9. Giorgadze TA, Peterman H, Baloch ZW, et al. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas. Cancer Cytopathol 2006;108:186-197.
10. Jhala N, Jhala D, Vichers SM, et al. Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol 2006;126:572-579.